Benitec Biopharma Limited Stock Based Compensation

Stock Based Compensation of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Stock Based Compensation growth rates and interactive chart.


Highlights and Quick Summary

  • Stock Based Compensation for the quarter ending September 30, 2022 was $302 Thousand (a 79.76% increase compared to previous quarter)
  • Year-over-year quarterly Stock Based Compensation increased by 26.36%
  • Annual Stock Based Compensation for 2022 was $870 Thousand (a 37.22% increase from previous year)
  • Annual Stock Based Compensation for 2021 was $634 Thousand (a 167.51% increase from previous year)
  • Annual Stock Based Compensation for 2020 was $237 Thousand (a -64.73% decrease from previous year)
  • Twelve month Stock Based Compensation ending September 30, 2022 was $901 Thousand (a 3.56% increase compared to previous quarter)
  • Twelve month trailing Stock Based Compensation decreased by -12.01% year-over-year
Trailing Stock Based Compensation for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$901 Thousand $870 Thousand $981 Thousand $1.02 Million
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Stock Based Compensation of Benitec Biopharma Limited

Most recent Stock Based Compensationof BNTC including historical data for past 10 years.

Interactive Chart of Stock Based Compensation of Benitec Biopharma Limited

Benitec Biopharma Limited Stock Based Compensation for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.3 $0.17 $0.19 $0.87
2021 $0.24 $0.27 $0.28 $0.24 $0.63
2020 $0.08 $0.04 $0.06 $0.18 $0.24
2019 $0.06 $0.67
2018 $0.34
2016 $1.27
2015 $1.26
2014 $0.33
2013 $0.53

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology